Selpercatinib in patients with treatment (Tx)-naïve RET-mutant medullary thyroid cancer (MTC)

Authors

Publication/Presentation Date

9-2020

Volume

31

Issue

4

First Page

1091

Last Page

1091

Department(s)

Hematology-Medical Oncology Division

Document Type

Article

Share

COinS